运动病
东莨菪碱
医学
药品
重症监护医学
耐火材料(行星科学)
物理医学与康复
药理学
精神科
物理
天体生物学
作者
Gayle B. Bodner,Courtney Perry
标识
DOI:10.1097/01.jaa.0000000000000097
摘要
ABSTRACT Patients who suffer from motion sickness despite avoiding triggers and using behavioral modifications may benefit from individualized recommendations for pharmacologic therapy. Patients with refractory motion sickness can benefit from prophylactic drug therapy using first-generation antihistamines or scopolamine.
科研通智能强力驱动
Strongly Powered by AbleSci AI